mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |